Table 1.
Clinicopathologic characteristics of the study sample. Values are counts (percentages) or mean ± standard deviation [interquartile range].
| Clinicopathologic Characteristics | n = 125 (%) |
|---|---|
| Age, years | 62.7 ± 10.7 |
| [56–71] | |
| Body mass index, kg/m2 | 27.5 ± 6.6 |
| [22.8–30.1] | |
| Tumor type | |
| Endometrioid | 90 (72.0) |
| Dedifferentiated/Undifferentiated | 17 (13.6) |
| Serous | 15 (12.0) |
| Clear cell | 3 (2.4) |
| Grade | |
| 1 | 36 (28.8) |
| 2 | 35 (28.0) |
| 3 | 54 (43.2) |
| Depth of invasion | |
| <50% | 90 (72.0) |
| ≥50% | 35 (28.0) |
| Lymphovascular space invasion (LVSI) | |
| Absent | 88 (70.4) |
| Present | 37 (29.6) |
| Lymph node status | |
| Negative | 95 (76.0) |
| Positive | 24 (19.2) |
| Unknown/Not tested | 6 (4.8) |
| FIGO stage | |
| IA | 71 (56.8) |
| IB | 18 (14.4) |
| II | 4 (3.2) |
| III | 30 (24.0) |
| IV | 2 (1.6) |
| ESMO (2016) | |
| Low | 18 (14.4) |
| Intermediate | 8 (6.4) |
| High–Intermediate | 42 (33.6) |
| High | 57 (45.6) |
| Extensive necrosis | |
| Absent | 66 (52.8) |
| Present | 59 (47.2) |
| MELF | |
| Absent | 79 (63.2) |
| Present | 46 (36.8) |
| Tumor budding | |
| Absent | 73 (58.4) |
| Present | 52 (41.6) |
| sTILs | |
| Low | 36 (28.8) |
| High | 89 (71.2) |
| iTILs | |
| Low | 39 (31.2) |
| High | 86 (68.8) |
| Recurrence | |
| Absent | 114 (91.2) |
| Present | 11 (8.8) |